Kollodis BioSciences, Inc.

General Information
Company Name
Kollodis BioSciences, Inc.
Founded Year
-
Location (Offices)
Founders / Decision Makers
Number of Employees
1
Industries
Biotechnology, Health Care
Funding Stage
-
Social Media

Kollodis BioSciences, Inc. - Company Profile

Kollodis BioSciences, Inc. is a biotechnology company specializing in bioadhesives and recombinant extracellular matrix (ECM) proteins for cell culture and related applications. The company offers a range of mussel adhesive protein (MAP) products, including stand-alone adhesives, adhesive kits, and specialized products for cell culture and tissue engineering. Its flagship product, the MAPTrix™ ECM line, comprises coating reagents with genetically incorporated bioactive peptides that mimic the activity of ECM proteins such as collagen, fibronectin, and laminin. These bioactive peptides facilitate cell attachment, spreading, and growth, while the mussel adhesive protein provides biocompatible adhesion to various surfaces. Additionally, the company offers the MAPTrix™ core product, recombinant mussel adhesive protein, and the MAPTrix HyGel™ line of chemically defined hydrogel products for 3D cell culture. Kollodis BioSciences, Inc. operates within the biotechnology and healthcare industries, positioning itself at the intersection of innovation and medical advancement. Through its unique product line, the company addresses the critical need for advanced cell culture and tissue engineering solutions, catering to the growing demand from biotech and healthcare professionals. However, key information such as the company's founding date, headquarters, and recent investments remains undisclosed, making it challenging to evaluate its current standing in the market. Investors seeking opportunities in the biotech and healthcare sectors may find Kollodis BioSciences, Inc. intriguing due to its focus on developing novel bioadhesives and ECM proteins. The company's innovative approach to cell culture and tissue engineering presents potential for market disruption and future growth. While additional details about recent investments and notable investors are unavailable at this time, Kollodis BioSciences, Inc. warrants further consideration for its unique product offerings and potential impact on the biotechnology landscape.

Funding Rounds & Investors of Kollodis BioSciences, Inc. (0)

View All

There is no investment information

Latest News of Kollodis BioSciences, Inc.

View All

No recent news or press coverage available for Kollodis BioSciences, Inc..

Similar Companies to Kollodis BioSciences, Inc.

View All

No funding or investment information available for Kollodis BioSciences, Inc. at this time.